Update: This event has been cancelled by the organizers. Thank you for your interest.
As an expert in immunogenicity screening, EpiVax’s CEO/CSO, Dr. Annie De Groot, will be conducting a training on state of the art methods of in silico and in vitro analysis to assess immunogenic risk of therapeutic proteins.
Please join us April 5th in Lyon to learn about the latest scientific advances in understanding the mechanisms of T cells and how to use these screening tools to meet the challenges of biomolecule development. Click here to register
We hope to see you there!